Skip to main content

Table 2 Perceived barriers to a more widespread adoption of active surveillance for Bosniak III-IV cysts (N = 128)

From: Management of complex renal cysts in Canada: results of a survey study

ConcernsDisagree
N (%)
Neither agree nor disagree
N (%)
Agree
N (%)
1) Patient and physician concerns regarding the oncologic safety and/or benefits of active surveillance.8 (6.3)5 (3.9)114 (89.8)
2) The psychological burden for the physicians or patients33 (25.8)29 (22.7)66 (51.6)
3) The belief that active surveillance is not an appropriate alternative since an effective surgical option already exists.43 (33.6)31 (24.2)54 (42.2)
4) The lack of data to support active surveillance in patients with BIII-IV17 (13.3)16 (12.5)95 (74.2)
5) The lack of specific triggers for intervention during active surveillance for cystic tumors11 (8.6)20 (15.6)97 (75.8)
6) The lack of guidance/knowledge/decision-aid tool on how to best manage and follow patients on active surveillance22 (17.2)30 (23.4)76 (59.4)
7) The belief that active surveillance is not an efficient trade-off to surgery because it increases the burden of care (i.e., more visits and repeated tests).69 (53.9)36 (28.1)23 (18.0)
8) The reliability of patients and the possibility of patients being lost to follow-up on active surveillance.47 (36.7)48 (37.5)33 (25.8)